| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| 2413.T - M3, Inc. | HOLD | 0 @ JPY 16.7194 | JPY 0 | The current share valuation price of 2413.T based on adjusted close was JPY 16.7194. The average price that 2413.T shares were previous bought at was JPY 14.4368. The current market price is 15.8% higher than average price they were purchased at. The value of the holding in 2413.T has fallen by JPY 5,485 compared to the previous valuation of M3, Inc. |
| 4151.T - Kyowa Kirin Co., Ltd. | HOLD | 0 @ JPY 16.8122 | JPY 0 | The current share valuation price of 4151.T based on adjusted close was JPY 16.8122. The average price that 4151.T shares were previous bought at was JPY 15.6831. The current market price is 7.2% higher than average price they were purchased at. The value of the holding in 4151.T has fallen by JPY 14,559 compared to the previous valuation of Kyowa Kirin Co., Ltd. |
| 4502.T - Takeda Pharmaceutical Company Limited | HOLD | 0 @ JPY 28.6729 | JPY 0 | The current share valuation price of 4502.T based on adjusted close was JPY 28.6729. The average price that 4502.T shares were previous bought at was JPY 28.7792. The current market price is -0.4% lower than average price they were purchased at. The value of the holding in 4502.T has fallen by JPY 10,834 compared to the previous valuation of Takeda Pharmaceutical Company Limited |
| 4503.T - Astellas Pharma Inc. | HOLD | 0 @ JPY 12.5804 | JPY 0 | The current share valuation price of 4503.T based on adjusted close was JPY 12.5804. The average price that 4503.T shares were previous bought at was JPY 10.8216. The current market price is 16.3% higher than average price they were purchased at. The value of the holding in 4503.T has fallen by JPY 49,564 compared to the previous valuation of Astellas Pharma Inc. |
| 4507.T - Shionogi & Co., Ltd. | HOLD | 0 @ JPY 17.2121 | JPY 0 | The current share valuation price of 4507.T based on adjusted close was JPY 17.2121. The average price that 4507.T shares were previous bought at was JPY 16.8914. The current market price is 1.9% higher than average price they were purchased at. The value of the holding in 4507.T has fallen by JPY 6,699 compared to the previous valuation of Shionogi & Co., Ltd. |
| 4519.T - Chugai Pharmaceutical Co., Ltd. | HOLD | 0 @ JPY 53.904 | JPY 0 | The current share valuation price of 4519.T based on adjusted close was JPY 53.904. The average price that 4519.T shares were previous bought at was JPY 46.605. The current market price is 15.7% higher than average price they were purchased at. The value of the holding in 4519.T has fallen by JPY 68,220 compared to the previous valuation of Chugai Pharmaceutical Co., Ltd. |
| 4523.T - Eisai Co., Ltd. | HOLD | 0 @ JPY 31.315 | JPY 0 | The current share valuation price of 4523.T based on adjusted close was JPY 31.315. The average price that 4523.T shares were previous bought at was JPY 30.3804. The current market price is 3.1% higher than average price they were purchased at. The value of the holding in 4523.T has fallen by JPY 87,622 compared to the previous valuation of Eisai Co., Ltd. |
| 4543.T - Terumo Corporation | HOLD | 0 @ JPY 15.5072 | JPY 0 | The current share valuation price of 4543.T based on adjusted close was JPY 15.5072. The average price that 4543.T shares were previous bought at was JPY 16.5774. The current market price is -6.5% lower than average price they were purchased at. The value of the holding in 4543.T has fallen by JPY 7,603 compared to the previous valuation of Terumo Corporation |
| 4568.T - Daiichi Sankyo Company, Limited | HOLD | 0 @ JPY 24.3611 | JPY 0 | The current share valuation price of 4568.T based on adjusted close was JPY 24.3611. The average price that 4568.T shares were previous bought at was JPY 24.0746. The current market price is 1.2% higher than average price they were purchased at. The value of the holding in 4568.T has fallen by JPY 77,263 compared to the previous valuation of Daiichi Sankyo Company, Limited |
| 4578.T - Otsuka Holdings Co., Ltd. | HOLD | 0 @ JPY 56.5589 | JPY 0 | The current share valuation price of 4578.T based on adjusted close was JPY 56.5589. The average price that 4578.T shares were previous bought at was JPY 53.3755. The current market price is 6.0% higher than average price they were purchased at. The value of the holding in 4578.T has fallen by JPY 10,573 compared to the previous valuation of Otsuka Holdings Co., Ltd. |
| 6869.T - Sysmex Corporation | HOLD | 0 @ JPY 9.628 | JPY 0 | The current share valuation price of 6869.T based on adjusted close was JPY 9.628. The average price that 6869.T shares were previous bought at was JPY 12.4691. The current market price is -22.8% lower than average price they were purchased at. The value of the holding in 6869.T has fallen by JPY 40,501 compared to the previous valuation of Sysmex Corporation |
| 7733.T - Olympus Corporation | HOLD | 0 @ JPY 13.4888 | JPY 0 | The current share valuation price of 7733.T based on adjusted close was JPY 13.4888. The average price that 7733.T shares were previous bought at was JPY 12.6037. The current market price is 7.0% higher than average price they were purchased at. The value of the holding in 7733.T has fallen by JPY 958 compared to the previous valuation of Olympus Corporation |
| 7741.T - HOYA Corporation | HOLD | 0 @ JPY 149.762 | JPY 0 | The current share valuation price of 7741.T based on adjusted close was JPY 149.762. The average price that 7741.T shares were previous bought at was JPY 145.222. The current market price is 3.1% higher than average price they were purchased at. The value of the holding in 7741.T has fallen by JPY 16,148 compared to the previous valuation of HOYA Corporation |
| A - Agilent Technologies Inc | HOLD | 0 @ USD 154.37 | USD 0 | The current share valuation price of A based on adjusted close was USD 154.37. The average price that A shares were previous bought at was USD 134.498. The current market price is 14.8% higher than average price they were purchased at. USD 0 compared to the previous valuation of Agilent Technologies Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ABBV - AbbVie Inc | HOLD | 0 @ USD 227.66 | USD 0 | The current share valuation price of ABBV based on adjusted close was USD 227.66. The average price that ABBV shares were previous bought at was USD 206.46. The current market price is 10.3% higher than average price they were purchased at. USD 0 compared to the previous valuation of AbbVie Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 128.54 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 128.54. The average price that ABT shares were previous bought at was USD 131.614. The current market price is -2.3% lower than average price they were purchased at. USD 0 compared to the previous valuation of Abbott Laboratories however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ALC.SW - | HOLD | 0 @ CHF 79.4039 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 79.4039. The average price that ALC.SW shares were previous bought at was CHF 77.7293. The current market price is 2.2% higher than average price they were purchased at. The value of the holding in ALC.SW has increased by CHF 1,771 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ALNY - Alnylam Pharmaceuticals Inc | HOLD | 0 @ USD 445.12 | USD 0 | The current share valuation price of ALNY based on adjusted close was USD 445.12. The average price that ALNY shares were previous bought at was USD 420.306. The current market price is 5.9% higher than average price they were purchased at. USD 0 compared to the previous valuation of Alnylam Pharmaceuticals Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| AMGN - Amgen Inc | HOLD | 0 @ USD 344.57 | USD 0 | The current share valuation price of AMGN based on adjusted close was USD 344.57. The average price that AMGN shares were previous bought at was USD 302.352. The current market price is 14.0% higher than average price they were purchased at. USD 0 compared to the previous valuation of Amgen Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 916.893 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 916.893. The average price that ARGX.BR shares were previous bought at was EUR 847.148. The current market price is 8.2% higher than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 32,909 compared to the previous valuation of Argenx SE |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 185.659 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 185.659. The average price that AZN.L shares were previous bought at was GBP 159.117. The current market price is 16.7% higher than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 211,324 compared to the previous valuation of AstraZeneca PLC |
| BAX - Baxter International Inc | HOLD | 0 @ USD 18.91 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 18.91. The average price that BAX shares were previous bought at was USD 19.5935. The current market price is -3.5% lower than average price they were purchased at. USD 0 compared to the previous valuation of Baxter International Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 35.5024 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 35.5024. The average price that BAYN.DE shares were previous bought at was EUR 31.4423. The current market price is 12.9% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 6,169 compared to the previous valuation of Bayer AG however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 193.9 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 193.9. The average price that BDX shares were previous bought at was USD 183.347. The current market price is 5.8% higher than average price they were purchased at. USD 0 compared to the previous valuation of Becton Dickinson and Company however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| BIIB - Biogen Inc | HOLD | 0 @ USD 181.94 | USD 0 | The current share valuation price of BIIB based on adjusted close was USD 181.94. The average price that BIIB shares were previous bought at was USD 173.846. The current market price is 4.7% higher than average price they were purchased at. USD 0 compared to the previous valuation of Biogen Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 126.728 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 126.728. The average price that BIM.PA shares were previous bought at was EUR 127.24. The current market price is -0.4% lower than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 1,714 compared to the previous valuation of BioMerieux |
| BMY - Bloomsbury Publishing Plc | HOLD | 0 @ USD 49.25 | USD 0 | The current share valuation price of BMY based on adjusted close was USD 49.25. The average price that BMY shares were previous bought at was USD 47.3663. The current market price is 4.0% higher than average price they were purchased at. USD 0 compared to the previous valuation of Bloomsbury Publishing Plc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 100.96 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 100.96. The average price that BSX shares were previous bought at was USD 101.156. The current market price is -0.2% lower than average price they were purchased at. USD 0 compared to the previous valuation of Boston Scientific Corporation however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 100.96 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 100.96. The average price that BSX shares were previous bought at was USD 101.156. The current market price is -0.2% lower than average price they were purchased at. USD 0 compared to the previous valuation of MULSTRXSSXIMETFP however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| CAH - Cardinal Health Inc | HOLD | 0 @ USD 213.14 | USD 0 | The current share valuation price of CAH based on adjusted close was USD 213.14. The average price that CAH shares were previous bought at was USD 167.417. The current market price is 27.3% higher than average price they were purchased at. USD 0 compared to the previous valuation of Cardinal Health Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| CI - Cigna Corp | HOLD | 0 @ USD 278.35 | USD 0 | The current share valuation price of CI based on adjusted close was USD 278.35. The average price that CI shares were previous bought at was USD 291.006. The current market price is -4.3% lower than average price they were purchased at. USD 0 compared to the previous valuation of Cigna Corp however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| CNC - Concurrent Technologies Plc | HOLD | 0 @ USD 39.46 | USD 0 | The current share valuation price of CNC based on adjusted close was USD 39.46. The average price that CNC shares were previous bought at was USD 38.4416. The current market price is 2.6% higher than average price they were purchased at. USD 0 compared to the previous valuation of Concurrent Technologies Plc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| COH.AX - | HOLD | 0 @ AUD 183.212 | AUD 0 | The current share valuation price of COH.AX based on adjusted close was AUD 183.212. The average price that COH.AX shares were previous bought at was AUD 185.819. The current market price is -1.4% lower than average price they were purchased at. The value of the holding in COH.AX has increased by AUD 38,033 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| COLO-B.CO - | HOLD | 0 @ DKK 90.6896 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 90.6896. The average price that COLO-B.CO shares were previous bought at was DKK 92.2349. The current market price is -1.7% lower than average price they were purchased at. The value of the holding in COLO-B.CO has increased by DKK 11,049 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| COO - The Cooper Companies, Inc. Common Stock | HOLD | 0 @ USD 77.94 | USD 0 | The current share valuation price of COO based on adjusted close was USD 77.94. The average price that COO shares were previous bought at was USD 75.6989. The current market price is 3.0% higher than average price they were purchased at. USD 0 compared to the previous valuation of The Cooper Companies, Inc. Common Stock however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| COR - Cencora Inc. | HOLD | 0 @ USD 368.53 | USD 0 | The current share valuation price of COR based on adjusted close was USD 368.53. The average price that COR shares were previous bought at was USD 320.421. The current market price is 15.0% higher than average price they were purchased at. USD 0 compared to the previous valuation of Cencora Inc. however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| CSL.AX - | HOLD | 0 @ AUD 121.641 | AUD 0 | The current share valuation price of CSL.AX based on adjusted close was AUD 121.641. The average price that CSL.AX shares were previous bought at was AUD 120.123. The current market price is 1.3% higher than average price they were purchased at. The value of the holding in CSL.AX has increased by AUD 65,583 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| CVS - CVS Health Corp | HOLD | 0 @ USD 79.86 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 79.86. The average price that CVS shares were previous bought at was USD 71.1294. The current market price is 12.3% higher than average price they were purchased at. USD 0 compared to the previous valuation of CVS Health Corp however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| DEMANT.CO - | HOLD | 0 @ DKK 33.997 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 33.997. The average price that DEMANT.CO shares were previous bought at was DKK 35.87. The current market price is -5.2% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 2,666 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| DGX - Quest Diagnostics Incorporated | HOLD | 0 @ USD 189.69 | USD 0 | The current share valuation price of DGX based on adjusted close was USD 189.69. The average price that DGX shares were previous bought at was USD 180.731. The current market price is 5.0% higher than average price they were purchased at. USD 0 compared to the previous valuation of Quest Diagnostics Incorporated however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| DHR - Danaher Corporation | HOLD | 0 @ USD 228.46 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 228.46. The average price that DHR shares were previous bought at was USD 209.968. The current market price is 8.8% higher than average price they were purchased at. USD 0 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| DHR - Danaher Corporation | HOLD | 0 @ USD 228.46 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 228.46. The average price that DHR shares were previous bought at was USD 209.968. The current market price is 8.8% higher than average price they were purchased at. USD 0 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 235.369 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 235.369. The average price that DIM.PA shares were previous bought at was EUR 220.814. The current market price is 6.6% higher than average price they were purchased at. The value of the holding in DIM.PA has increased by EUR 3,467 compared to the previous valuation of Sartorius Stedim Biotech however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| DXCM - DexCom Inc | HOLD | 0 @ USD 62.53 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 62.53. The average price that DXCM shares were previous bought at was USD 69.4664. The current market price is -10.0% lower than average price they were purchased at. USD 0 compared to the previous valuation of DexCom Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 363.024 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 363.024. The average price that EL.PA shares were previous bought at was EUR 342.762. The current market price is 5.9% higher than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 3,184 compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 338.52 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 338.52. The average price that ELV shares were previous bought at was USD 335.766. The current market price is 0.8% higher than average price they were purchased at. USD 0 compared to the previous valuation of Elevance Health Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 338.52 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 338.52. The average price that ELV shares were previous bought at was USD 335.766. The current market price is 0.8% higher than average price they were purchased at. USD 0 compared to the previous valuation of Elevance Health Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 68.6859 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 68.6859. The average price that ERF.PA shares were previous bought at was EUR 69.3899. The current market price is -1.0% lower than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 977 compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 86.75 | USD 0 | The current share valuation price of EW based on adjusted close was USD 86.75. The average price that EW shares were previous bought at was USD 78.715. The current market price is 10.2% higher than average price they were purchased at. USD 0 compared to the previous valuation of Edwards Lifesciences Corp however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 47.6999 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 47.6999. The average price that FME.DE shares were previous bought at was EUR 50.9587. The current market price is -6.4% lower than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 403 compared to the previous valuation of Fresenius Medical Care AG |
| FPH.NZ - | HOLD | 0 @ NZD 21.6194 | NZD 0 | The current share valuation price of FPH.NZ based on adjusted close was NZD 21.6194. The average price that FPH.NZ shares were previous bought at was NZD 21.1253. The current market price is 2.3% higher than average price they were purchased at. The value of the holding in FPH.NZ has fallen by NZD 2,640 compared to the previous valuation of |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 54.9116 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 54.9116. The average price that FRE.DE shares were previous bought at was EUR 52.4017. The current market price is 4.8% higher than average price they were purchased at. The value of the holding in FRE.DE has fallen by EUR 124 compared to the previous valuation of Fresenius SE & Co KGaA |
| GALD.SW - | HOLD | 0 @ CHF 198.075 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 198.075. The average price that GALD.SW shares were previous bought at was CHF 184.4. The current market price is 7.4% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 10,807 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 80.6301 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 80.6301. The average price that GEHC shares were previous bought at was USD 75.4292. The current market price is 6.9% higher than average price they were purchased at. USD 0 compared to the previous valuation of GE HealthCare Technologies Inc. however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| GILD - Guild Esports Plc | HOLD | 0 @ USD 127.51 | USD 0 | The current share valuation price of GILD based on adjusted close was USD 127.51. The average price that GILD shares were previous bought at was USD 116.15. The current market price is 9.8% higher than average price they were purchased at. USD 0 compared to the previous valuation of Guild Esports Plc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 315.287 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 315.287. The average price that GMAB.CO shares were previous bought at was DKK 280.97. The current market price is 12.2% higher than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 39,926 compared to the previous valuation of |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 12.2786 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 12.2786. The average price that GRF.MC shares were previous bought at was EUR 13.2076. The current market price is -7.0% lower than average price they were purchased at. The value of the holding in GRF.MC has increased by EUR 2,764 compared to the previous valuation of Grifols SA however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 23.8765 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 23.8765. The average price that GSK.L shares were previous bought at was GBP 23.2527. The current market price is 2.7% higher than average price they were purchased at. The value of the holding in GSK.L has fallen by GBP 24,606 compared to the previous valuation of GlaxoSmithKline PLC |
| HCA - HCA Holdings Inc | HOLD | 0 @ USD 514.76 | USD 0 | The current share valuation price of HCA based on adjusted close was USD 514.76. The average price that HCA shares were previous bought at was USD 438.288. The current market price is 17.4% higher than average price they were purchased at. USD 0 compared to the previous valuation of HCA Holdings Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 20.8025 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 20.8025. The average price that HIK.L shares were previous bought at was GBP 22.9595. The current market price is -9.4% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 2,295 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.9025 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.9025. The average price that HLN.L shares were previous bought at was GBP 4.88935. The current market price is 0.3% higher than average price they were purchased at. The value of the holding in HLN.L has fallen by GBP 682 compared to the previous valuation of Haleon PLC |
| HOLX - Hologic Inc | HOLD | 0 @ USD 74.8 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 74.8. The average price that HOLX shares were previous bought at was USD 69.7374. The current market price is 7.3% higher than average price they were purchased at. USD 0 compared to the previous valuation of Hologic Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| HUM - Hummingbird Resources PLC | HOLD | 0 @ USD 245.99 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 245.99. The average price that HUM shares were previous bought at was USD 267.564. The current market price is -8.1% lower than average price they were purchased at. USD 0 compared to the previous valuation of Hummingbird Resources PLC however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| HUM - Humana Inc | HOLD | 0 @ USD 245.99 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 245.99. The average price that HUM shares were previous bought at was USD 267.564. The current market price is -8.1% lower than average price they were purchased at. USD 0 compared to the previous valuation of Humana Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 755.96 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 755.96. The average price that IDXX shares were previous bought at was USD 609.637. The current market price is 24.0% higher than average price they were purchased at. USD 0 compared to the previous valuation of IDEXX Laboratories Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ILMN - Illumina Inc | HOLD | 0 @ USD 129.81 | USD 0 | The current share valuation price of ILMN based on adjusted close was USD 129.81. The average price that ILMN shares were previous bought at was USD 102.955. The current market price is 26.1% higher than average price they were purchased at. USD 0 compared to the previous valuation of Illumina Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| INCY - Incyte Corporation | HOLD | 0 @ USD 105.65 | USD 0 | The current share valuation price of INCY based on adjusted close was USD 105.65. The average price that INCY shares were previous bought at was USD 103.737. The current market price is 1.8% higher than average price they were purchased at. USD 0 compared to the previous valuation of Incyte Corporation however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| INSM - Insmed Inc | HOLD | 0 @ USD 204.51 | USD 0 | |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 144.236 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 144.236. The average price that IPN.PA shares were previous bought at was EUR 135.691. The current market price is 6.3% higher than average price they were purchased at. The value of the holding in IPN.PA has fallen by EUR 1,329 compared to the previous valuation of Ipsen SA |
| IQV - IQVIA Holdings Inc | HOLD | 0 @ USD 231.8 | USD 0 | The current share valuation price of IQV based on adjusted close was USD 231.8. The average price that IQV shares were previous bought at was USD 195.252. The current market price is 18.7% higher than average price they were purchased at. USD 0 compared to the previous valuation of IQVIA Holdings Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 574.23 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 574.23. The average price that ISRG shares were previous bought at was USD 538.222. The current market price is 6.7% higher than average price they were purchased at. USD 0 compared to the previous valuation of Intuitive Surgical Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| JNJ - Johnson & Johnson | HOLD | 0 @ USD 207.56 | USD 0 | The current share valuation price of JNJ based on adjusted close was USD 207.56. The average price that JNJ shares were previous bought at was USD 169.389. The current market price is 22.5% higher than average price they were purchased at. USD 0 compared to the previous valuation of Johnson & Johnson however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| LH - Laboratory Corporation of America Holdings | HOLD | 0 @ USD 268.27 | USD 0 | The current share valuation price of LH based on adjusted close was USD 268.27. The average price that LH shares were previous bought at was USD 262.51. The current market price is 2.2% higher than average price they were purchased at. USD 0 compared to the previous valuation of Laboratory Corporation of America Holdings however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| LLY - Eli Lilly and Company | HOLD | 0 @ USD 1104.34 | USD 0 | The current share valuation price of LLY based on adjusted close was USD 1104.34. The average price that LLY shares were previous bought at was USD 835.036. The current market price is 32.3% higher than average price they were purchased at. USD 0 compared to the previous valuation of Eli Lilly and Company however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 679.044 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 679.044. The average price that LONN.SW shares were previous bought at was CHF 676.753. The current market price is 0.3% higher than average price they were purchased at. The value of the holding in LONN.SW has increased by CHF 11,199 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| MCK - McKesson Corporation | HOLD | 0 @ USD 883.71 | USD 0 | The current share valuation price of MCK based on adjusted close was USD 883.71. The average price that MCK shares were previous bought at was USD 778.024. The current market price is 13.6% higher than average price they were purchased at. USD 0 compared to the previous valuation of McKesson Corporation however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| MDT - Medtronic PLC | HOLD | 0 @ USD 105.02 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 105.02. The average price that MDT shares were previous bought at was USD 97.2856. The current market price is 8.0% higher than average price they were purchased at. USD 0 compared to the previous valuation of Medtronic PLC however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| MRK - Marks Electrical Group PLC | HOLD | 0 @ USD 104.63 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 104.63. The average price that MRK shares were previous bought at was USD 84.0604. The current market price is 24.5% higher than average price they were purchased at. USD 0 compared to the previous valuation of Marks Electrical Group PLC however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| MRK - Merck & Company Inc | HOLD | 0 @ USD 104.63 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 104.63. The average price that MRK shares were previous bought at was USD 84.0604. The current market price is 24.5% higher than average price they were purchased at. USD 0 compared to the previous valuation of Merck & Company Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 134.264 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 134.264. The average price that MRK.DE shares were previous bought at was EUR 130.447. The current market price is 2.9% higher than average price they were purchased at. The value of the holding in MRK.DE has increased by EUR 287 compared to the previous valuation of Merck KGaA however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| MTD - Mettler-Toledo International Inc | HOLD | 0 @ USD 1486.55 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1486.55. The average price that MTD shares were previous bought at was USD 1463.69. The current market price is 1.6% higher than average price they were purchased at. USD 0 compared to the previous valuation of Mettler-Toledo International Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| MTD - AMUNDI EUR GOV 710 | HOLD | 0 @ USD 1486.55 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1486.55. The average price that MTD shares were previous bought at was USD 1463.69. The current market price is 1.6% higher than average price they were purchased at. USD 0 compared to the previous valuation of AMUNDI EUR GOV 710 however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| NBIX - Neurocrine Biosciences Inc | HOLD | 0 @ USD 151.58 | USD 0 | The current share valuation price of NBIX based on adjusted close was USD 151.58. The average price that NBIX shares were previous bought at was USD 140.213. The current market price is 8.1% higher than average price they were purchased at. USD 0 compared to the previous valuation of Neurocrine Biosciences Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 129.947 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 129.947. The average price that NOVN.SW shares were previous bought at was CHF 123.74. The current market price is 5.0% higher than average price they were purchased at. The value of the holding in NOVN.SW has fallen by CHF 184,337 compared to the previous valuation of |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 48.2633 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 48.2633. The average price that NOVO-B.CO shares were previous bought at was DKK 55.9384. The current market price is -13.7% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 145,680 compared to the previous valuation of Novo Nordisk A/S |
| NTRA - Natera Inc | HOLD | 0 @ USD 237.12 | USD 0 | The current share valuation price of NTRA based on adjusted close was USD 237.12. The average price that NTRA shares were previous bought at was USD 173.306. The current market price is 36.8% higher than average price they were purchased at. USD 0 compared to the previous valuation of Natera Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 71.4802 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 71.4802. The average price that ORNBV.HE shares were previous bought at was EUR 67.8405. The current market price is 5.4% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 3,834 compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| PFE - Pfizer Inc | HOLD | 0 @ USD 25.71 | USD 0 | The current share valuation price of PFE based on adjusted close was USD 25.71. The average price that PFE shares were previous bought at was USD 24.7625. The current market price is 3.8% higher than average price they were purchased at. USD 0 compared to the previous valuation of Pfizer Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 28.0934 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 28.0934. The average price that PHIA.AS shares were previous bought at was EUR 26.5139. The current market price is 6.0% higher than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 398 compared to the previous valuation of Koninklijke Philips NV |
| PME.AX - | HOLD | 0 @ AUD 174.242 | AUD 0 | The current share valuation price of PME.AX based on adjusted close was AUD 174.242. The average price that PME.AX shares were previous bought at was AUD 181.215. The current market price is -3.8% lower than average price they were purchased at. The value of the holding in PME.AX has increased by AUD 6,026 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| PODD - Insulet Corporation | HOLD | 0 @ USD 326.8 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 326.8. The average price that PODD shares were previous bought at was USD 333.441. The current market price is -2.0% lower than average price they were purchased at. USD 0 compared to the previous valuation of Insulet Corporation however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 48.0534 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 48.0534. The average price that QIA.DE shares were previous bought at was EUR 45.759. The current market price is 5.0% higher than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 31,636 compared to the previous valuation of QIAGEN NV |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 58.5523 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 58.5523. The average price that REC.MI shares were previous bought at was EUR 58.4515. The current market price is 0.2% higher than average price they were purchased at. The value of the holding in REC.MI has fallen by EUR 167 compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA |
| REGN - Regeneron Pharmaceuticals Inc | HOLD | 0 @ USD 784.61 | USD 0 | The current share valuation price of REGN based on adjusted close was USD 784.61. The average price that REGN shares were previous bought at was USD 712.428. The current market price is 10.1% higher than average price they were purchased at. USD 0 compared to the previous valuation of Regeneron Pharmaceuticals Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| RMD - ResMed Inc | HOLD | 0 @ USD 255.04 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 255.04. The average price that RMD shares were previous bought at was USD 256.073. The current market price is -0.4% lower than average price they were purchased at. USD 0 compared to the previous valuation of ResMed Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| RO.SW - | HOLD | 0 @ CHF 397.889 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 397.889. The average price that RO.SW shares were previous bought at was CHF 343.117. The current market price is 16.0% higher than average price they were purchased at. The value of the holding in RO.SW has fallen by CHF 53,002 compared to the previous valuation of |
| ROG.SW - | HOLD | 0 @ CHF 384.104 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 384.104. The average price that ROG.SW shares were previous bought at was CHF 359.664. The current market price is 6.8% higher than average price they were purchased at. The value of the holding in ROG.SW has fallen by CHF 192,182 compared to the previous valuation of |
| RPRX - Royalty Pharma Plc | HOLD | 0 @ USD 39.84 | USD 0 | The current share valuation price of RPRX based on adjusted close was USD 39.84. The average price that RPRX shares were previous bought at was USD 36.7765. The current market price is 8.3% higher than average price they were purchased at. USD 0 compared to the previous valuation of Royalty Pharma Plc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 99.5852 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 99.5852. The average price that SAN.PA shares were previous bought at was EUR 99.0472. The current market price is 0.5% higher than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 19,226 compared to the previous valuation of Sanofi SA |
| SDZ.SW - | HOLD | 0 @ CHF 69.7671 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 69.7671. The average price that SDZ.SW shares were previous bought at was CHF 57.9682. The current market price is 20.4% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 545 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SHL.AX - | HOLD | 0 @ AUD 15.2557 | AUD 0 | The current share valuation price of SHL.AX based on adjusted close was AUD 15.2557. The average price that SHL.AX shares were previous bought at was AUD 15.0663. The current market price is 1.3% higher than average price they were purchased at. The value of the holding in SHL.AX has increased by AUD 723 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 49.5549 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 49.5549. The average price that SHL.DE shares were previous bought at was EUR 53.4708. The current market price is -7.3% lower than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 3,246 compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SIG.AX - | HOLD | 0 @ AUD 1.88818 | AUD 0 | The current share valuation price of SIG.AX based on adjusted close was AUD 1.88818. The average price that SIG.AX shares were previous bought at was AUD 1.89691. The current market price is -0.5% lower than average price they were purchased at. The value of the holding in SIG.AX has fallen by AUD 8,323 compared to the previous valuation of |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 16.6818 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 16.6818. The average price that SN.L shares were previous bought at was GBP 17.294. The current market price is -3.5% lower than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 423 compared to the previous valuation of Smith & Nephew PLC |
| SOBI.ST - | HOLD | 0 @ SEK 36.2432 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 36.2432. The average price that SOBI.ST shares were previous bought at was SEK 32.9135. The current market price is 10.1% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 4,257 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SOLV - Solventum Corp. | HOLD | 0 @ USD 85.2701 | USD 0 | The current share valuation price of SOLV based on adjusted close was USD 85.2701. The average price that SOLV shares were previous bought at was USD 72.4742. The current market price is 17.7% higher than average price they were purchased at. USD 0 compared to the previous valuation of Solventum Corp. however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 249.86 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 249.86. The average price that SOON.SW shares were previous bought at was CHF 275.476. The current market price is -9.3% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 54,391 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 284.529 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 284.529. The average price that SRT3.DE shares were previous bought at was EUR 254.653. The current market price is 11.7% higher than average price they were purchased at. The value of the holding in SRT3.DE has increased by EUR 27,510 compared to the previous valuation of Sartorius AG however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| STE - STERIS plc | HOLD | 0 @ USD 266.85 | USD 0 | The current share valuation price of STE based on adjusted close was USD 266.85. The average price that STE shares were previous bought at was USD 240.814. The current market price is 10.8% higher than average price they were purchased at. USD 0 compared to the previous valuation of STERIS plc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| STMN.SW - | HOLD | 0 @ CHF 116.113 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 116.113. The average price that STMN.SW shares were previous bought at was CHF 121.695. The current market price is -4.6% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 9,779 compared to the previous valuation of |
| SYK - Stryker Corporation | HOLD | 0 @ USD 372.29 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 372.29. The average price that SYK shares were previous bought at was USD 370.329. The current market price is 0.5% higher than average price they were purchased at. USD 0 compared to the previous valuation of Stryker Corporation however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| TEVA - Teva Pharma Industries Ltd ADR | HOLD | 0 @ USD 26.32 | USD 0 | The current share valuation price of TEVA based on adjusted close was USD 26.32. The average price that TEVA shares were previous bought at was USD 19.0228. The current market price is 38.4% higher than average price they were purchased at. USD 0 compared to the previous valuation of Teva Pharma Industries Ltd ADR however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| TMO - Time Out Group plc | HOLD | 0 @ USD 593.25 | USD 0 | The current share valuation price of TMO based on adjusted close was USD 593.25. The average price that TMO shares were previous bought at was USD 477.707. The current market price is 24.2% higher than average price they were purchased at. USD 0 compared to the previous valuation of Time Out Group plc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 276.529 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 276.529. The average price that UCB.BR shares were previous bought at was EUR 248.44. The current market price is 11.3% higher than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 19,567 compared to the previous valuation of UCB SA however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| UNH - UnitedHealth Group Incorporated | HOLD | 0 @ USD 329.71 | USD 0 | The current share valuation price of UNH based on adjusted close was USD 329.71. The average price that UNH shares were previous bought at was USD 320.557. The current market price is 2.9% higher than average price they were purchased at. USD 0 compared to the previous valuation of UnitedHealth Group Incorporated however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| UTHR - United Therapeutics Corporation | HOLD | 0 @ USD 488.43 | USD 0 | The current share valuation price of UTHR based on adjusted close was USD 488.43. The average price that UTHR shares were previous bought at was USD 419.012. The current market price is 16.6% higher than average price they were purchased at. USD 0 compared to the previous valuation of United Therapeutics Corporation however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| VEEV - Veeva Systems Inc Class A | HOLD | 0 @ USD 240.67 | USD 0 | The current share valuation price of VEEV based on adjusted close was USD 240.67. The average price that VEEV shares were previous bought at was USD 284.797. The current market price is -15.5% lower than average price they were purchased at. USD 0 compared to the previous valuation of Veeva Systems Inc Class A however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| VRTX - Vertex Pharmaceuticals Inc | HOLD | 0 @ USD 432.17 | USD 0 | The current share valuation price of VRTX based on adjusted close was USD 432.17. The average price that VRTX shares were previous bought at was USD 423.38. The current market price is 2.1% higher than average price they were purchased at. USD 0 compared to the previous valuation of Vertex Pharmaceuticals Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| WAT - Waters Corporation | HOLD | 0 @ USD 407.14 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 407.14. The average price that WAT shares were previous bought at was USD 337.329. The current market price is 20.7% higher than average price they were purchased at. USD 0 compared to the previous valuation of Waters Corporation however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| WAT - MULETFWATIMETFP | HOLD | 0 @ USD 407.14 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 407.14. The average price that WAT shares were previous bought at was USD 337.329. The current market price is 20.7% higher than average price they were purchased at. USD 0 compared to the previous valuation of MULETFWATIMETFP however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| WST - West Pharmaceutical Services Inc | HOLD | 0 @ USD 277.14 | USD 0 | The current share valuation price of WST based on adjusted close was USD 277.14. The average price that WST shares were previous bought at was USD 264.273. The current market price is 4.9% higher than average price they were purchased at. USD 0 compared to the previous valuation of West Pharmaceutical Services Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 97.55 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 97.55. The average price that ZBH shares were previous bought at was USD 97.2797. The current market price is 0.3% higher than average price they were purchased at. USD 0 compared to the previous valuation of Zimmer Biomet Holdings Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ZTS - Zoetis Inc | HOLD | 0 @ USD 127.69 | USD 0 | The current share valuation price of ZTS based on adjusted close was USD 127.69. The average price that ZTS shares were previous bought at was USD 139.124. The current market price is -8.2% lower than average price they were purchased at. USD 0 compared to the previous valuation of Zoetis Inc however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |